Synthesis, Characterization of Dextran Hydrogels and Their in Vitro Release of Gentamycin Sulphate
Source abstract
Abstract
Purpose This study reports on the synthesis and characterization of biodegradable dextran–allyl isocyanate–ethylamine (Dex-AE)/polyethylene glycol–diacrylate (PEGDA) hydrogels for the controlled release of gentamycin sulphate (GS) and in vitro inhibition of organisms. Methods The Dex-AE precursor was prepared through a 2-step chemical modification and characterized by Fourier transform infrared spectroscopy (FTIR). Results Scanning electron microscopy (SEM) results revealed that an increase in Dex-AE content led to an initial decrease in pore size of the Dex-AE/PEGDA hydrogels, but a further increase in Dex-AE content resulted in a slightly increase of pore size. The swelling data indicated that the swelling ratio depended on the precursor feed ratio. GS was incorporated into the hydrogels through 2 different methods, i.e., immersed and crosslinked. The crosslinked GS-Dex-AE/PEGDA hydorgels exhibited stronger antimicrobial activities against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. Finally, the viscoelastic properties of crosslinked GS-Dex-AE/PEGDA hydorgels were investigated.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · biodegradable polymer synthesis and properties · Antimicrobial agents and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Jinan University, Guangzhou - China
Department of Biomedical Engineering, Jinan University, Guangzhou - China
Department of Chemistry, Jinan University, Guangzhou - China
References (23)
Show source-provided references
1. 10.1128/AAC.01803-1010.1128/AAC.01803-10 ↗
2. 10.1166/jbn.2013.150910.1166/jbn.2013.1509 ↗
3. 10.1179/joc.1998.10.3.20810.1179/joc.1998.10.3.208 ↗
4. 10.1016/S0378-8741(03)00044-810.1016/S0378-8741(03)00044-8 ↗
5. 10.1097/TA.0b013e3181c9c07410.1097/TA.0b013e3181c9c074 ↗
6. 10.1016/S0169-409X(01)00239-310.1016/S0169-409X(01)00239-3 ↗
7. 10.1073/pnas.111597310810.1073/pnas.1115973108 ↗
8. 10.1016/j.biomaterials.2008.11.02310.1016/j.biomaterials.2008.11.023 ↗
9. 10.1016/j.biomaterials.2010.08.08410.1016/j.biomaterials.2010.08.084 ↗
10. 10.1002/jbm.b.3052210.1002/jbm.b.30522 ↗
11. 10.1038/sj.mt.630015610.1038/sj.mt.6300156 ↗
12. 10.1016/j.biomaterials.2006.06.00410.1016/j.biomaterials.2006.06.004 ↗
13. 10.2217/nnm.12.14910.2217/nnm.12.149 ↗
14. 10.1016/j.msec.2013.03.02510.1016/j.msec.2013.03.025 ↗
15. Sun G · J Biomed Mater Res A · 2010 · 93 · 108010.1002/jbm.a.32604 ↗
16. 10.1016/j.biomaterials.2010.08.09110.1016/j.biomaterials.2010.08.091 ↗
17. 10.1208/s12249-010-9474-010.1208/s12249-010-9474-0 ↗
18. 10.1016/j.actbio.2014.03.02910.1016/j.actbio.2014.03.029 ↗
19. 10.1016/j.carbpol.2006.01.01510.1016/j.carbpol.2006.01.015 ↗
20. 10.1016/j.carbpol.2010.12.01710.1016/j.carbpol.2010.12.017 ↗
21. 10.1002/1099-0518(20000701)38:13<2392::AID-POLA120>3.0.CO;2-P10.1002/1099-0518(20000701)38:13<2392::AID-POLA120>3.0.CO;2-P ↗
22. 10.1016/S0268-005X(03)00087-010.1016/S0268-005X(03)00087-0 ↗
23. 10.1016/j.jcis.2005.04.02610.1016/j.jcis.2005.04.026 ↗